Revenue

TOYO Co., Ltd. is betting its future on controlling the entire solar supply chain. As its CSO meets investors, can this bold strategy navigate trade risks?

Amber International's bold pivot to specialized AI agents is already a financial success, with new 'agentic' revenue driving a return to profitability.

United Imaging's revolutionary dual wide-coverage CT scanners have gained European approval, promising to redefine diagnostics and challenge market leaders.

A top EV battery supplier just went public on the NYSE, but its real target is the AI boom. Can Londian Wason transform into a key player in NVIDIA's world?

Hello Group's Q2 earnings reveal a tale of two companies: a booming international segment masks a struggling core business in China. Is this global pivot a masterstroke or a desperate bet?

A late SEC filing and a prior 'going concern' warning reveal deep financial turmoil at the specialty coffee innovator, raising questions about its future.

Facing delisting, BioRestorative executes another reverse split. We dive into whether this financial maneuver can sustain it or just delays the inevitable.

Cabbacis is pitching its patented, very-low-nicotine hemp cigarettes to investors, betting its future on a proposed FDA rule to slash nicotine in tobacco.

As fintech giant nCino heads to a key investor conference, its 'agentic AI banking' vision is under the microscope. What's behind the buzzword?

A 65-year-old Pennsylvania engineering firm gets a new name. But behind the rebrand is a global giant's aggressive strategy to dominate the infrastructure boom.

Medici Brands just raised $250M, but the story isn't the money. It's the hidden tech platform, built on a proprietary fat substitute, that's upending CPG.

As Stoke prepares for a key investor conference, its lead drug zorevunersen nears a pivotal Phase 3 readout, promising a new era for patients and the RNA platform.

Fresh from bankruptcy, iRobot launches its most advanced Roomba. But in a market swamped by rivals, is this high-tech offensive enough to reclaim its throne?

As specialty contractor MYR Group meets with top investors, its strategy reveals a bigger story: how firms building our green infrastructure are Wall Street's new darlings.

As Alamar Biosciences prepares for a key fireside chat at Morgan Stanley, all eyes are on its NULISA™ technology and its rapid commercial growth.

GitLab posts strong 21% revenue growth, leveraging its financial momentum to double down on AI and flexible enterprise models, navigating a complex market.

As Chipotle prepares its Q3 2026 report, investors are watching if its tech-forward strategy and premium brand can overcome industry headwinds and market pressures.

The cybersecurity giant posts stellar growth fueled by its AI strategy and a key acquisition, but a widening gap between official and adjusted profits raises questions.

Granted a 180-day Nasdaq extension, AI infrastructure firm Alpha Compute must now prove its high-tech vision is more than a penny stock reality.

Applied Aerospace & Defense appoints Elizabeth Robertson, a former NASA engineer, to drive growth, signaling a strategic push into mission-critical programs.